• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDINAL HEALTH SANTA CLARA MYNXGRIP; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDINAL HEALTH SANTA CLARA MYNXGRIP; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number MX5021
Device Problems Decrease in Pressure (1490); Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/13/2023
Event Type  malfunction  
Manufacturer Narrative
This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the balloon of a 5f mynx grip vascular closure device (vcd) burst during prep.Therefore, the product wasn¿t available and manual compression was performed for 20 minutes and recovered.There were no reports of patient injury.The mynx grip vcd was prepared and used in accordance with the instructions for use (ifu).The mynx vcd used in transfemoral cerebral angiography (tfca).There were no visible signs of device/package damage prior to use.The physician achieved certification on the use of mynx and has used the device several times prior to this procedure.There was no excessive force used when removing the device from its packaging.The device will be returned for evaluation.
 
Manufacturer Narrative
Complaint conclusion: as reported, the balloon of a 5f mynx grip vascular closure device (vcd) burst during prep.Therefore, the product wasn¿t available and manual compression was performed for 20 minutes and recovered.There were no reports of patient injury.The mynx grip vcd was prepared and used in accordance with the instructions for use (ifu).The mynx vcd used in transfemoral cerebral angiography (tfca).There were no visible signs of device/package damage prior to use.The physician achieved certification on the use of mynx and has used the device several times prior to this procedure.There was no excessive force used when removing the device from its packaging.A non-sterile ¿mynxgrip vascular closure device 5f¿ was returned for evaluation.Per visual inspection, the shuttle was engaged to the black handle.The syringe and procedure sheath were received for evaluation and the stopcock was found open.The sealant and advancer tube remained in the manufacturing position.The balloon was received fully deflated.Visual inspection at high magnification revealed a longitudinal tear in the balloon of the return device.Additionally, the sealant was observed to be remaining in the manufacturing position.The reported ¿balloon-balloon loss of pressure¿ was confirmed.Balloon loss of pressure was caused by a longitudinal tear in the balloon.The exact cause of the issues experienced could not be determined.Based on the information available for review, it is not possible to determine what factors may have contributed to the loss of pressure reported.However, prepping/handling factors are likely related factors.According to the ifu, which is not intended as a mitigation, ¿the safety and effectiveness of the mynxgrip have not been established in the following patient populations: patients with clinically significant peripheral vascular disease in the vicinity of the puncture.¿ also stated in the ifu, "inflate the balloon until the black marker on the inflation indicator is fully visible.Check for leaks in the balloon and the syringe connector; retighten if necessary.Discard the device if the balloon does not maintain pressure.Check for air bubbles in the balloon.If air bubbles are visible, deflate the balloon, draw vacuum to remove bubbles and re-inflate." the available information does not suggest that the reported failures could be related to the design or manufacturing process of the units.Therefore, no corrective/preventative actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNXGRIP
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CARDINAL HEALTH SANTA CLARA
5452 betsy ross drive
santa clara, california 95054
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes, florida 33014
Manufacturer Contact
karla castro
5452 betsy ross drive
santa clara, california 95054
7863138372
MDR Report Key18223504
MDR Text Key329435843
Report Number3004939290-2023-03505
Device Sequence Number1
Product Code MGB
UDI-Device Identifier10862028000403
UDI-Public10862028000403
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMX5021
Device Lot NumberF2318605
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/16/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/03/2023
Initial Date FDA Received11/28/2023
Supplement Dates Manufacturer Received01/10/2024
Supplement Dates FDA Received01/18/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-